These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 36338493)

  • 1. Effects of cannabinoids on ligand-gated ion channels.
    Oz M; Yang KS; Mahgoub MO
    Front Physiol; 2022; 13():1041833. PubMed ID: 36338493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
    De Petrocellis L; Di Marzo V
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.
    Oz M
    Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.
    Wiley JL; Owens RA; Lichtman AH
    Curr Top Behav Neurosci; 2018; 39():153-173. PubMed ID: 27278640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium channels as molecular targets of endocannabinoids.
    Lin YF
    Channels (Austin); 2021 Dec; 15(1):408-423. PubMed ID: 34282702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
    J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions and Regulation of Ionotropic Cannabinoid Receptors.
    De Petrocellis L; Nabissi M; Santoni G; Ligresti A
    Adv Pharmacol; 2017; 80():249-289. PubMed ID: 28826537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products.
    An D; Peigneur S; Hendrickx LA; Tytgat J
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosanoid mediation of cannabinoid actions.
    Burstein SH
    Bioorg Med Chem; 2019 Jul; 27(13):2718-2728. PubMed ID: 31104784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol.
    Wright NJD
    AIMS Neurosci; 2024; 11(2):144-165. PubMed ID: 38988890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-independent effects of endocannabinoids on ion channels.
    Oz M
    Curr Pharm Des; 2006; 12(2):227-39. PubMed ID: 16454739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.
    Hiley CR; Ford WR
    Biol Rev Camb Philos Soc; 2004 Feb; 79(1):187-205. PubMed ID: 15005177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors.
    Grassin-Delyle S; Naline E; Buenestado A; Faisy C; Alvarez JC; Salvator H; Abrial C; Advenier C; Zemoura L; Devillier P
    Br J Pharmacol; 2014 Jun; 171(11):2767-77. PubMed ID: 24467410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.